A first of its kind pilot that will in January begin monitoring patients on specialty drugs in real-time is a partnership between UMass Medical School and tech startup InterVRX, according to an article in Specialty Pharmacy Continuum.

UMass Medical School’s Clinical Pharmacy Services has partnered with InterVRx to review the accuracy, completeness and usability of specialty drug clinical protocols used within its patient monitoring platform.